| 000 | 01621 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250513231545.0 | ||
| 264 | 0 | _c20010201 | |
| 008 | 200102s 0 0 eng d | ||
| 022 | _a0077-8923 | ||
| 024 | 7 |
_a10.1111/j.1749-6632.2000.tb07045.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMiyamoto, S | |
| 245 | 0 | 0 |
_aCellular and molecular responses to topoisomerase I poisons. Exploiting synergy for improved radiotherapy. _h[electronic resource] |
| 260 |
_bAnnals of the New York Academy of Sciences _c2000 |
||
| 300 |
_a274-92 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCattle |
| 650 | 0 | 4 |
_aDNA Topoisomerases, Type I _xphysiology |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNAD(P)H Dehydrogenase (Quinone) _xbiosynthesis |
| 650 | 0 | 4 |
_aNF-kappa B _xphysiology |
| 650 | 0 | 4 |
_aNaphthoquinones _xpharmacology |
| 650 | 0 | 4 |
_aRadiation-Sensitizing Agents _xpharmacology |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 | _aTopoisomerase I Inhibitors |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 700 | 1 | _aHuang, T T | |
| 700 | 1 | _aWuerzberger-Davis, S | |
| 700 | 1 | _aBornmann, W G | |
| 700 | 1 | _aPink, J J | |
| 700 | 1 | _aTagliarino, C | |
| 700 | 1 | _aKinsella, T J | |
| 700 | 1 | _aBoothman, D A | |
| 773 | 0 |
_tAnnals of the New York Academy of Sciences _gvol. 922 _gp. 274-92 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1749-6632.2000.tb07045.x _zAvailable from publisher's website |
| 999 |
_c11132085 _d11132085 |
||